urea has been researched along with Herpes Genitalis in 4 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Herpes Genitalis: Infection of the genitals (GENITALIA) with HERPES SIMPLEX VIRUS in either the males or the females.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ugaonkar, SR | 1 |
| Wesenberg, A | 1 |
| Wilk, J | 1 |
| Seidor, S | 2 |
| Mizenina, O | 2 |
| Kizima, L | 1 |
| Rodriguez, A | 1 |
| Zhang, S | 3 |
| Levendosky, K | 1 |
| Kenney, J | 2 |
| Aravantinou, M | 2 |
| Derby, N | 2 |
| Grasperge, B | 1 |
| Gettie, A | 2 |
| Blanchard, J | 2 |
| Kumar, N | 1 |
| Roberts, K | 1 |
| Robbiani, M | 2 |
| Fernández-Romero, JA | 3 |
| Zydowsky, TM | 3 |
| Villegas, G | 1 |
| Calenda, G | 1 |
| Kleinbeck, K | 1 |
| Cooney, ML | 1 |
| Hoesley, CJ | 1 |
| Creasy, GW | 1 |
| Friedland, B | 1 |
| Teleshova, N | 1 |
| Singer, R | 1 |
| Abraham, CJ | 1 |
| Menon, R | 1 |
| Piatak, M | 1 |
| Lifson, JD | 1 |
| Sakakibara, T | 1 |
| Hata, M | 1 |
| Numano, K | 1 |
| Kawase, Y | 1 |
| Yamanishi, T | 1 |
| Kawana, S | 1 |
| Tsuboi, N | 1 |
1 trial available for urea and Herpes Genitalis
| Article | Year |
|---|---|
In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa.
Topics: Administration, Intravaginal; Anti-Infective Agents; Body Fluids; Coinfection; Female; Gels; Herpes | 2016 |
3 other studies available for urea and Herpes Genitalis
| Article | Year |
|---|---|
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
Topics: Administration, Intravaginal; Animals; Antiviral Agents; Carrageenan; Cell Line; Contraceptive Agent | 2015 |
A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use.
Topics: Administration, Intravaginal; Administration, Rectal; Animals; Anti-Infective Agents; Female; Herpes | 2012 |
Fixed-drug eruption caused by allylisopropylacetylurea.
Topics: Adult; Diagnosis, Differential; Drug Eruptions; Female; Herpes Genitalis; Humans; Hypnotics and Seda | 2001 |